Wiegand SJ - Search Results

1

Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishikawa S. Uemura A, et al. Among authors: wiegand sj. J Clin Invest. 2002 Dec;110(11):1619-28. doi: 10.1172/JCI15621. J Clin Invest. 2002. PMID: 12464667 Free PMC article.

2

Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes.

Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S. Uemura A, et al. Among authors: wiegand sj. J Clin Invest. 2006 Feb;116(2):369-77. doi: 10.1172/JCI25964. Epub 2006 Jan 19. J Clin Invest. 2006. PMID: 16424942 Free PMC article.

3

Angiopoietin-2 plays an important role in retinal angiogenesis.

Hackett SF, Wiegand S, Yancopoulos G, Campochiaro PA. Hackett SF, et al. J Cell Physiol. 2002 Aug;192(2):182-7. doi: 10.1002/jcp.10128. J Cell Physiol. 2002. PMID: 12115724

4

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. Poulaki V, et al. Among authors: wiegand sj. J Clin Invest. 2002 Mar;109(6):805-15. doi: 10.1172/JCI13776. J Clin Invest. 2002. PMID: 11901189 Free PMC article.

5

New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Holash J, Wiegand SJ, Yancopoulos GD. Holash J, et al. Among authors: wiegand sj. Oncogene. 1999 Sep 20;18(38):5356-62. doi: 10.1038/sj.onc.1203035. Oncogene. 1999. PMID: 10498889 Review.

6

Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period.

Thurston G, Wang Q, Baffert F, Rudge J, Papadopoulos N, Jean-Guillaume D, Wiegand S, Yancopoulos GD, McDonald DM. Thurston G, et al. Development. 2005 Jul;132(14):3317-26. doi: 10.1242/dev.01888. Epub 2005 Jun 15. Development. 2005. PMID: 15958513

7

Suppression of diabetic retinopathy with angiopoietin-1.

Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, Ioffe E, Yancopoulos GD, Adamis AP. Joussen AM, et al. Among authors: wiegand sj. Am J Pathol. 2002 May;160(5):1683-93. doi: 10.1016/S0002-9440(10)61115-7. Am J Pathol. 2002. PMID: 12000720 Free PMC article.

8

Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Gale NW, et al. Among authors: wiegand sj. Dev Cell. 2002 Sep;3(3):411-23. doi: 10.1016/s1534-5807(02)00217-4. Dev Cell. 2002. PMID: 12361603 Free article.

9

The anti-inflammatory actions of angiopoietin-1.

Thurston G, Rudge JS, Ioffe E, Papadopoulos N, Daly C, Vuthoori S, Daly T, Wiegand SJ, Yancopoulos GD. Thurston G, et al. Among authors: wiegand sj. EXS. 2005;(94):233-45. doi: 10.1007/3-7643-7311-3_16. EXS. 2005. PMID: 15617482 Review. No abstract available.

10

Vascular-specific growth factors and blood vessel formation.

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Yancopoulos GD, et al. Among authors: wiegand sj. Nature. 2000 Sep 14;407(6801):242-8. doi: 10.1038/35025215. Nature. 2000. PMID: 11001067 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page